-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 I+R6arOlZDYfOfdJ5/31i48DnWtIpbhqcuvECm4zATg52K2S5NlTauAbxVnJHvce
 KL3C5Za5E+b0o8QBY50J9A==

<SEC-DOCUMENT>0001424590-08-000003.txt : 20080911
<SEC-HEADER>0001424590-08-000003.hdr.sgml : 20080911
<ACCEPTANCE-DATETIME>20080911152330
ACCESSION NUMBER:		0001424590-08-000003
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20080909
FILED AS OF DATE:		20080911
DATE AS OF CHANGE:		20080911

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DARA BioSciences, Inc.
		CENTRAL INDEX KEY:			0000919745
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				043216862
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		8601 SIX FORKS ROAD SUITE 160
		CITY:			RALEIGH
		STATE:			NC
		ZIP:			27615
		BUSINESS PHONE:		919-861-0202

	MAIL ADDRESS:	
		STREET 1:		8601 SIX FORKS ROAD SUITE 160
		CITY:			RALEIGH
		STATE:			NC
		ZIP:			27615

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DARA BIOSCIENCES INC
		DATE OF NAME CHANGE:	20080211

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	POINT THERAPEUTICS INC
		DATE OF NAME CHANGE:	20020328

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HMSR INC
		DATE OF NAME CHANGE:	20010618

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Didsbury John
		CENTRAL INDEX KEY:			0001424590

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-23776
		FILM NUMBER:		081067215

	BUSINESS ADDRESS:	
		BUSINESS PHONE:		919.861.0198

	MAIL ADDRESS:	
		STREET 1:		4505 FALLS OF NEUSE ROAD SUITE 125
		CITY:			RALEIGH
		STATE:			NC
		ZIP:			27609
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>primary_doc.xml
<DESCRIPTION>PRIMARY DOCUMENT
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0303</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2008-09-09</periodOfReport>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0000919745</issuerCik>
        <issuerName>DARA BioSciences, Inc.</issuerName>
        <issuerTradingSymbol>DARA</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001424590</rptOwnerCik>
            <rptOwnerName>Didsbury John</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O DARA BIOSCIENCES, INC.</rptOwnerStreet1>
            <rptOwnerStreet2>4505 FALLS OF NEUSE ROAD SUITE 125</rptOwnerStreet2>
            <rptOwnerCity>RALEIGH</rptOwnerCity>
            <rptOwnerState>NC</rptOwnerState>
            <rptOwnerZipCode>27609</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>1</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle>COO and Chief Scientic Officer</officerTitle>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeHolding>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>9000</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeHolding>
    </nonDerivativeTable>

    <derivativeTable>
        <derivativeTransaction>
            <securityTitle>
                <value>Option to Buy</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>1.4</value>
            </conversionOrExercisePrice>
            <transactionDate>
                <value>2008-09-09</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionTimeliness>
                <value></value>
            </transactionTimeliness>
            <transactionAmounts>
                <transactionShares>
                    <value>250000</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>0</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <exerciseDate>
                <footnoteId id="F1"/>
            </exerciseDate>
            <expirationDate>
                <value>2018-09-09</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>250000</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>250000</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeTransaction>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">This option was granted on September 9, 2008 and provides for vesting in four equal installments, with the first installment vesting upon grant and the remaining installments vesting annually thereafter.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>John Didsbury By Mark R. Busch, Attorney-in-Fact</signatureName>
        <signatureDate>2008-09-11</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----